1. Home/
  2. Compounds/
  3. alisertib:navitoclax (2:1 mol/mol)

alisertib:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2alisertib:navitoclax (2:1 mol/mol)
PharmacoGx alisertib:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to alisertib:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ADAM22 CTRPv2 pan-cancer AAC 0.18 6e-06
mRNA ADAMTSL2 CTRPv2 pan-cancer AAC 0.13 0.0001
mRNA ADAMTSL5 CTRPv2 pan-cancer AAC -0.12 0.0009
mRNA ADARB2 CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA ADAT2 CTRPv2 pan-cancer AAC 0.17 5e-05
mRNA ADD2 CTRPv2 pan-cancer AAC 0.12 0.0006
mRNA ADGRB2 CTRPv2 pan-cancer AAC 0.15 5e-05
mRNA ADGRF3 CTRPv2 pan-cancer AAC 0.12 0.002
mRNA ADGRL1 CTRPv2 pan-cancer AAC 0.16 4e-05
mRNA ADGRV1 CTRPv2 pan-cancer AAC 0.12 0.0005
Download CSV